Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Cognitive Dysfunction × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2 Neoplasms 2 Sturge-Weber Syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Epilepsy 1 Cognitive Dysfunction 1 Carcinoma, Hepatocellular 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03047980 2021-11-01

Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Phase 2/3 Completed

10 enrolled 11 charts

Sturge-Weber Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡